View : 21 Download: 0

Sequential VAD (Vincristine, Adriamycin, Dexamethasone) and VTD (Bortezomib, Thalidomide, Dexamethasone) Induction Followed by High-Dose Therapy with Autologous Stem Cell Transplantation and Maintenance Treatment with Bortezomib for Newly Diagnosed Multiple Myeloma: Final Analysis of Phase II Trial

Title
Sequential VAD (Vincristine, Adriamycin, Dexamethasone) and VTD (Bortezomib, Thalidomide, Dexamethasone) Induction Followed by High-Dose Therapy with Autologous Stem Cell Transplantation and Maintenance Treatment with Bortezomib for Newly Diagnosed Multiple Myeloma: Final Analysis of Phase II Trial
Authors
Yoon, Suno-SooKim, Hye JinChung, Joo SeopEom, HyeonSeokJang, Jun-HoKang, Hye JinKim, Cheol SooKim, KihyunLee, DongsoonLee, Jae HoonLee, JunglimLee, Sang JaeMin, Yoo HongSeong, Chu-MyongSohn, Sang-KyunSuh, CheolwonWon, Jong-Ho
Ewha Authors
성주명
SCOPUS Author ID
성주명scopus
Issue Date
2008
Journal Title
BLOOD
ISSN
0006-4971JCR Link
Citation
vol. 112, no. 11, pp. 1144 - 1144
Publisher
AMER SOC HEMATOLOGY
Indexed
SCI; SCIE; SCOPUS WOS
Appears in Collections:
의과대학 > 의학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE